These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18631168)

  • 1. Validation of HLAMatchmaker algorithm in identifying acceptable HLA mismatches for thrombocytopenic patients refractory to platelet transfusions.
    Brooks EG; MacPherson BR; Fung MK
    Transfusion; 2008 Oct; 48(10):2159-66. PubMed ID: 18631168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
    Duquesnoy RJ; Howe J; Takemoto S
    Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients.
    Nambiar A; Duquesnoy RJ; Adams S; Zhao Y; Oblitas J; Leitman S; Stroncek D; Marincola F
    Blood; 2006 Feb; 107(4):1680-7. PubMed ID: 16269623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.
    Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH
    Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural epitope matching for HLA-alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support?
    Duquesnoy RJ
    Transfusion; 2008 Feb; 48(2):221-7. PubMed ID: 18005328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttransfusion platelet count increments after ABO-compatible versus ABO-incompatible platelet transfusions in noncancer patients: an observational study.
    Pavenski K; Warkentin TE; Shen H; Liu Y; Heddle NM
    Transfusion; 2010 Jul; 50(7):1552-60. PubMed ID: 20210928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).
    Wiita AP; Nambiar A
    Transfusion; 2012 Oct; 52(10):2146-54. PubMed ID: 23113654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-selected platelets for platelet refractory patients with HLA antibodies: a single-center experience.
    Karlström C; Linjama T; Edgren G; Lauronen J; Wikman A; Höglund P
    Transfusion; 2019 Mar; 59(3):945-952. PubMed ID: 30575964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of cross-matched or HLA-matched platelets for patients refractory to platelet transfusion.
    Rioux-Massé B; Cohn C; Lindgren B; Pulkrabek S; McCullough J
    Transfusion; 2014 Dec; 54(12):3080-7. PubMed ID: 24916382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
    Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
    Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the effectiveness of whole blood-derived platelets stored as a pool: a randomized block noninferiority trial.
    Heddle NM; Cook RJ; Blajchman MA; Barty RL; Sigouin CS; Boye DM; Nelson EJ; Kelton JG
    Transfusion; 2005 Jun; 45(6):896-903. PubMed ID: 15934987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can thrombocyte crossmatching improve the efficiency of platelet transfusion?].
    Weisbach V; Zeiler T; Zingsem J; Musch R; Heuft HG; Eckstein R
    Beitr Infusionsther; 1990; 26():160-2. PubMed ID: 1703820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical impact of platelet refractoriness: correlation with bleeding and survival.
    Kerkhoffs JL; Eikenboom JC; van de Watering LM; van Wordragen-Vlaswinkel RJ; Wijermans PW; Brand A
    Transfusion; 2008 Sep; 48(9):1959-65. PubMed ID: 18564396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light.
    Murphy S; Snyder E; Cable R; Slichter SJ; Strauss RG; McCullough J; Lin JS; Corash L; Conlan MG;
    Transfusion; 2006 Jan; 46(1):24-33. PubMed ID: 16398727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients.
    Fontaine MJ; Kuo J; Chen G; Galel SA; Miller E; Sequeira F; Viele M; Goodnough LT; Tyan DB
    Transfusion; 2011 Dec; 51(12):2611-8. PubMed ID: 21615749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient and product factors affecting platelet transfusion results.
    Heim D; Passweg J; Gregor M; Buser A; Theocharides A; Arber C; Meyer-Monard S; Halter J; Tichelli A; Gratwohl A
    Transfusion; 2008 Apr; 48(4):681-7. PubMed ID: 18208413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
    Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
    Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients.
    Menitove JE; Duquesnoy RJ
    Am J Med Technol; 1981 Feb; 47(2):114-20. PubMed ID: 7223758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very high users of platelet transfusions in the neonatal intensive care unit.
    Dohner ML; Wiedmeier SE; Stoddard RA; Null D; Lambert DK; Burnett J; Baer VL; Hunt JC; Henry E; Christensen RD
    Transfusion; 2009 May; 49(5):869-72. PubMed ID: 19175546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.